Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 186 of 1,261
  1. US 11684761

    Preparation comprising exanatide for delivery into a lumen of the intestinal tract

    Rani Therapeutics, LLC · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  2. US 11686735

    Systems and methods to identify and treat subjects at risk for obstetrical complications

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  3. US 11684612

    Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator

    Corcept Therapeutics Incorporated · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  4. US 11685710

    Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids

    The Board of Regents of the University of Texas System · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  5. US 11684600

    Composition of active agents to positively affect a robust mammalian endocannabinoid system tone to better address age related discomfort

    COMPACT DISC INCORPORATED · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  6. US 11684638

    Targeted delivery system, system components, and methods

    Regents of the University of Minnesota · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  7. US 11684632

    Maribavir isomers, compositions, methods of making and methods of using

    Takeda Pharmaceutical Company Limited · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  8. US 11685750

    Crystalline forms of IRAK degraders

    Kymera Therapeutics, Inc. · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  9. US 11685784

    Anti-immune-checkpoint nanobody and nucleic acid encoding sequence thereof, and uses of the same

    China Medical University Hospital · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  10. US 11685746

    Heteroaryl compounds for treating Huntington's disease

    PTC THERAPEUTICS, INC. · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  11. US 11685775

    Method of increasing the ratio of effector T cells to regulatory T cells in a tumor by administering to a subject a TGF-beta inhibitor and a PD-1 antibody

    The Regents of the University of California · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  12. US 11685749

    C26-linked rapamycin analogs as mTOR inhibitors

    Revolution Medicines, Inc. · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  13. US 11685780

    Single domain antigen binding domains that bind human Trop2

    Takeda Pharmaceutical Company Limited · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  14. US 11685771

    Recombinant factor VIII proteins

    BIOVERATIV THERAPEUTICS INC. · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  15. US 11684597

    Administration of tailored feedstock to increase nitro-containing amphenicol antibiotic susceptibility

    The United States of America as represented by the Secretary of the Army · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  16. US 11685721

    Human plasma kallikrein inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  17. US 11685744

    CDK inhibitors and their use as pharmaceuticals

    Prelude Therapeutics, Incorporated · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  18. US 11685921

    Molecules and agents for treating hepatitis B virus

    ARCTURUS THERAPEUTICS, INC. · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  19. US 11685918

    Programmed cell death 1 ligand 1 (PD-L1) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  20. US 11685906

    Compositions and methods for treating ornithine transcarbamylase deficiency

    ARCTURUS THERAPEUTICS, INC. · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  21. US 11684050

    Non-human animals having a humanized programmed cell death 1 gene

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  22. US 11684596

    Antidiabetic pharmaceutical compositions and preparation method thereof

    Elite Pharmaceutical Solution Inc. · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  23. CA 3242445

    POLYPEPTIDES COMPRENANT DES DOMAINES VARIABLES UNIQUES D'IMMUNOGLOBULINE CIBLANT TCRAS, CD33 ET CD123

    ABLYNX NV [BE] · Granted Jun 22, 2023 · Expires Jun 17, 2043

    granted
  24. US 11679158

    Biodegradable lipids for the delivery of active agents

    Alnylam Pharmaceuticals, Inc. · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.